Circulation. 2007;115:1622-1633
doi: 10.1161/CIRCULATIONAHA.105.592428
(Circulation. 2007;115:1622-1633.)
© 2007 American Heart Association, Inc.
Congenital Heart Disease for the Adult Cardiologist |
Interventional Catheterization in Adult Congenital Heart Disease
Ignacio Inglessis, MD;
Michael J. Landzberg, MD
From the Boston Adult Congenital Heart Group (I.I., M.J.L.), Massachusetts General Hospital (I.I.), Boston Childrens Hospital (I.I., M.J.L.), Brigham and Womens Hospital (M.J.L.), and Beth Israel Deaconess Hospital (M.J.L.), Harvard Medical School, Boston, Mass.
Correspondence and reprint requests to Michael J. Landzberg, MD, Boston Childrens Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail michael.landzberg@cardio.chboston.org
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
Improved medical and surgical therapies for children with congenital
heart disease have resulted in a growing population of patients
reaching adulthood.
1,2 Over this same time, the field of interventional
cardiology has experienced significant growth, driven by technological
improvements and better understanding of the mechanisms and
intermediate-term results of individual procedures. Consequently,
for adults with uncorrected or previously palliated congenital
heart disease, percutaneous therapies have increasing acceptance
as reasonable additions, alternatives, and treatments of choice
when further surgical or medical intervention is contemplated
(Table 1). Currently, interventional cardiology of adult congenital
heart disease (ACHD) is a well-established field on its own
and, programmatically, is a fundamental component of any center
providing care for these patients.
3 Although limited safety
of interventional procedures for the ACHD population has been
suggested in centers without ACHD global care programs,
4 the
wide variation in clinical presentation, novelty of cardiovascular
pathologies (with similarity to as well as marked differences
from both congenital and acquired conditions), and potential
for concomitant multiple organ system pathology all contribute
to situations atypical for standard adult or pediatric laboratories.
These concerns, combined with a desire to centralize data collection
to establish outcomes assessments for ACHD patients considered
for interventional catheterization, lead to the recommendation
that such procedures be performed in centers with ACHD expertise
and established care programs.
3
View this table:
|
TABLE 1. Commonly Practiced Catheter-Based Interventions in ACHD: Indications and Level of Evidence
|
|
In this article, we review the most commonly performed percutaneous procedures in ACHD, including valvuloplasty, angioplasty, and device closures. . . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
Z. M. Hijazi and S. M. Awad
Pediatric Cardiac Interventions
J. Am. Coll. Cardiol. Intv.,
December 1, 2008;
1(6):
603 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Rhodes, Z. M. Hijazi, and R. J. Sommer
Pathophysiology of Congenital Heart Disease in the Adult, Part II: Simple Obstructive Lesions
Circulation,
March 4, 2008;
117(9):
1228 - 1237.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bedard, D. F. Shore, and M. A. Gatzoulis
Adult congenital heart disease: a 2008 overview
Br. Med. Bull.,
March 1, 2008;
85(1):
151 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|